If you have noticed more hair in your brush or shower drain since starting Ozempic, you are not imagining it. Ozempic hair loss threads on Reddit and elsewhere are full of similar stories. The short answer to whether Ozempic causes hair loss is more specific than yes or no. The shedding people report usually appears linked to weight loss itself, especially fast weight loss, rather than direct damage to hair follicles [1, 2].

This article covers what that shedding is and what the data show. It also covers who may be more likely to notice it and when hair loss may point to something else. It is educational and not medical advice. Any change to your medication or treatment plan is a conversation for your provider.

The short answer

Hair loss is not listed among the side effects seen in the Ozempic diabetes trials. Alopecia, the medical term for hair loss, appears only in the post-marketing section of the Ozempic label, which collects reports after approval [3]. Wegovy, the higher-dose weight-management version of semaglutide, does list hair loss in its trial data. Those cases were more common in people who lost more weight [4].

That pattern matches a well-known type of shedding called telogen effluvium. It can follow many kinds of physical stress, including rapid weight loss, and it is usually temporary [2].

What is telogen effluvium?

Each hair on your scalp cycles through phases. Most hairs are in a growth phase at any given time. A smaller share sits in a resting phase before falling out and being replaced [2].

A significant stress on the body can push a larger share of hairs into the resting phase at once. Common triggers include illness, surgery, childbirth, major emotional stress, and rapid weight loss or sharply reduced food intake [2, 5]. Hairs rest for a few months before they shed. So the extra shedding typically shows up two to four months after the trigger, not right away [2].

Telogen effluvium tends to look like this [2]:

  • Diffuse thinning across the scalp, not bald patches
  • More hairs than usual coming out when you wash or brush
  • No scarring, redness, or scaling on the scalp
  • Gradual improvement once the trigger settles, often over about six months

Weight loss surgery offers a useful comparison. Hair shedding after bariatric surgery is a recognized issue. It is often tied to the speed of weight loss and to nutritional shortfalls during that period [5]. GLP-1 medications are different treatments, but the body's response to fast weight loss can follow a similar pattern.

What the clinical trial data show

The labels give the most controlled numbers available.

  • Ozempic (semaglutide, type 2 diabetes): alopecia is listed only from post-marketing reports, with no trial rate [3].
  • Wegovy (semaglutide, weight management): hair loss was reported in about 3% of adults on Wegovy versus about 1% on placebo. It was reported more often in people who lost 20% or more of their body weight [4].
  • Zepbound (tirzepatide, weight management): hair loss was reported in 4% to 5% of people across doses versus 1% on placebo [6]. It was reported far more often in women (7.1%) than men (0.5%), with placebo rates of 1.3% and 0% [6].

The link to the amount of weight lost is the key clue. It suggests the shedding tracks with how fast and how much weight comes off, which fits telogen effluvium [4].

What larger studies of GLP-1 hair loss suggest

Outside trials, researchers have looked at health records and adverse event reports. A 2026 systematic review found that semaglutide and tirzepatide had the highest reported rates of hair loss among GLP-1 medications [1]. Telogen effluvium and pattern hair loss were the main types identified [1]. The review pointed to rapid weight loss as a likely contributor, particularly for telogen effluvium [1].

A large 2026 cohort study using medical records reached a similar conclusion. Semaglutide and tirzepatide were associated with higher odds of nonscarring hair loss, and the authors suggested that weight-loss-related physical stress may play a role [7].

These studies show associations, not proof of cause. They rely on diagnosis codes and reports, which can miss mild cases or capture unrelated ones. Researchers have called for more rigorous studies to define the risk more precisely [1].

Who may be more likely to notice it

Will Ozempic cause hair loss for you specifically? No one can predict that. The research does point to a few factors that seem to matter.

  • Speed and amount of weight loss: hair loss was reported more often with greater weight loss in the Wegovy trials [4].
  • Sex: women reported hair loss far more often than men in the Zepbound trials [6].
  • Nutrition during weight loss: low intake of protein, iron, zinc, or overall energy is a known trigger for shedding [5, 8].
  • Existing hair conditions: some people with pattern hair loss may notice it becoming more visible during a period of shedding [1].

Eating less is part of how GLP-1 medications work, so nutrition deserves attention. That does not mean following a strict tracking plan. If tracking or restricting food feels stressful, raise that with a clinician.

What may help

There is no proven treatment that stops telogen effluvium once it starts [2]. The focus is on reducing triggers and giving hair time to recover.

  • Talk to your provider about pace. A provider can review how quickly your weight is changing and whether your dose schedule needs a look. No dose change has been proven to prevent hair loss.
  • Keep eating enough, especially protein. Shedding is linked to low protein and nutrient intake during weight loss [5, 8]. A provider or registered dietitian can help you plan meals that work with a smaller appetite. Our GLP-1 nutrition guide covers food choices in more detail.
  • Ask about possible deficiencies. Your own provider may suggest bloodwork, such as iron or thyroid tests, if your history points that way [8].
  • Be gentle with your hair. Tight hairstyles, harsh treatments, and heat can add breakage on top of shedding.
  • Give it time. Because of the delay built into the hair cycle, improvement often lags behind any change you make by several months [2]. Photos taken a few weeks apart in the same light can help you judge progress more fairly than daily checks in the mirror.

Hair shedding can be upsetting, even when it is temporary. If it is affecting how you feel about treatment, say so. Your provider can weigh that alongside everything else in your plan.

When hair loss may be something else

Not every hair change during GLP-1 treatment is telogen effluvium. Contact a healthcare provider if you notice:

  • Round or patchy bald spots, which can signal alopecia areata
  • Redness, scaling, pain, or itching on the scalp
  • Hair loss with no recent weight loss or other clear trigger
  • Shedding that continues well beyond six months or keeps getting worse
  • Other new symptoms, such as fatigue, feeling cold, or changes in your periods, which can point to thyroid or iron problems [2, 8]

A dermatologist can examine your scalp and help sort out the cause.

Common questions

Is the hair loss permanent?
Telogen effluvium is usually temporary. Most people see improvement within about six months once the trigger settles, though timing varies [2]. If shedding continues much longer, see a provider to check for other causes.

Does tirzepatide cause it too?
Yes, hair loss has been reported with tirzepatide. In Zepbound trials, it was reported in 4% to 5% of people versus 1% on placebo, and much more often in women [6]. Like semaglutide, the reports appear tied to weight reduction [1, 6].

Do biotin or other supplements help?
The evidence is limited. A review found little support for biotin in people who are not deficient [9]. High-dose biotin can also interfere with some lab tests, according to the FDA, so tell your provider if you take it [10]. A provider can help decide whether a specific supplement makes sense.

Should I stop my medication?
Do not stop or change your dose on your own. That decision belongs to you and your provider together. Shedding that has already started may continue for a while after any change, because those hairs entered the resting phase months earlier [2]. Like any prescription medication, semaglutide carries risks and possible side effects your provider will review with you.

Next steps

If any of this sounds like what you are dealing with, the next step is a conversation with a licensed provider who can review your history and decide whether treatment makes sense for you. Nothing is prescribed or shipped without that review. The medication you select is a preference and a starting point, not a purchase; a provider approves it or recommends something more suitable.

Explore Luvo's Weight Loss Program.

Sources

  1. Gupta AK, Teasell EM, Economopoulos V, Mirmirani P. GLP-1 therapies and hair loss: a systematic review of current evidence and implications for counseling. Sci Prog. 2026. doi:10.1177/00368504261444578
  2. Hughes EC, Syed HA, Saleh D. Telogen effluvium. StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430848/
  3. Novo Nordisk. Ozempic (semaglutide) injection, for subcutaneous use. US prescribing information. https://www.novo-pi.com/ozempic.pdf
  4. Novo Nordisk. Wegovy (semaglutide) injection, for subcutaneous use. US prescribing information. https://www.novo-pi.com/wegovy.pdf
  5. Guo EL, Katta R. Diet and hair loss: effects of nutrient deficiency and supplement use. Dermatol Pract Concept. 2017;7(1):1-10. doi:10.5826/dpc.0701a01
  6. Eli Lilly and Company. Zepbound (tirzepatide) injection, for subcutaneous use. US prescribing information, revised February 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf
  7. Nonscarring alopecia in adults treated with GLP-1s: a propensity score matched TriNetX cohort study. 2026. PubMed ID 42647098. https://pubmed.ncbi.nlm.nih.gov/42647098/
  8. Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The role of vitamins and minerals in hair loss: a review. Dermatol Ther (Heidelb). 2019;9(1):51-70. doi:10.1007/s13555-018-0278-6
  9. Soleymani T, Lo Sicco K, Shapiro J. The infatuation with biotin supplementation: is there truth behind its rising popularity? A comparative analysis of clinical efficacy versus social popularity. J Drugs Dermatol. 2017;16(5):496-500.
  10. US Food and Drug Administration. UPDATE: The FDA warns that biotin may interfere with lab tests: FDA safety communication. 2019. https://www.fda.gov/medical-devices/safety-communications/update-fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication

This article is for general educational purposes and is not medical advice. It is not a substitute for a conversation with a licensed healthcare provider about your own health. Prescription treatments require provider review and approval. Individual results vary.

If your symptoms are severe, worsening, or new, contact a healthcare provider. If this is an emergency, call 911 or go to the nearest emergency room.

This article does not provide calorie, macronutrient, or portion targets. If tracking food or restricting intake causes you distress, bring it up with a clinician before making changes.

Ozempic, Wegovy, and Zepbound are the trademarks of their respective owners. Luvo Health is not affiliated with, endorsed by, or sponsored by any of them.